0
Summaries for Patients |

Naloxone for Heroin Overdose Reversal FREE

[+] Article and Author Information

The full report is titled “Cost-Effectiveness of Distributing Naloxone to Heroin Users for Lay Overdose Reversal.” It is in the 1 January 2013 issue of Annals of Internal Medicine (volume 158, pages 1-9). The authors are P.O. Coffin and S.D. Sullivan.


Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.

Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians.


Ann Intern Med. 2013;158(1):I-30. doi:10.7326/0003-4819-158-1-201301010-00001
Text Size: A A A

What is the problem and what is known about it so far?

In the United States, drug overdose is a leading cause of death. In some areas, public health departments are providing heroin users with naloxone, a drug that counters the effects of heroin, to use when they have overdosed on heroin or are with someone who has overdosed. Naloxone can often reverse the negative effects of heroin on breathing and other body functions, thereby preventing death and disability.

Why did the researchers do this particular study?

To find out how much it would cost per year of life gained to provide naloxone kits to heroin users and witnesses to heroin overdoses.

Who was studied?

The researchers did not study real patients. Instead, they developed a computer simulation that estimated what would happen if heroin users and those around them had naloxone in their possession and administered it during a heroin overdose.

How was the study done?

The researchers based the computer model on estimates from previous studies to determine how many overdose deaths might be prevented by distributing naloxone to heroin users and people likely to witness a heroin overdose. They also looked at the cost of providing naloxone in this way to calculate how much providing naloxone would cost per year of life gained.

What were the limitations of the study?

Computer simulations cannot definitively show what would happen in the real world. The model did not consider other positive aspects of naloxone distribution programs, such as reduced drug use resulting from peer education.

What are the implications of the study?

Distributing naloxone to heroin users to reverse overdose would be well within the range that U.S. society is typically willing to pay for health treatments.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)